"Microdosing" has officially arrived in the GLP-1 world, and like most wellness trends, it's a tangle of one reasonable idea wrapped in a lot of marketing. My goal here is to help you pull those two apart, because the reasonable idea is worth understanding and the marketing is worth resisting, and they often arrive in the same sentence.
First, a clarification that matters more than it sounds: "microdosing" is not an official medical term, and it's not an FDA-approved protocol with a defined meaning. It's a popular, fuzzy label for using lower-than-standard doses, and different people and different sellers mean different things by it. That vagueness is itself the first thing to be skeptical of. Whenever a term is loose enough to mean whatever the person selling it wants it to mean, you should hold onto your wallet a little tighter and ask what, specifically, they're actually talking about.
Now, the reasonable kernel inside the trend, because there genuinely is one. Dosing these medications is not one-size-fits-all, and more is emphatically not automatically better. The standard, sound approach is to start low and increase slowly, and plenty of people do very well, and tolerate side effects considerably better, at doses below the maximum. Some people reach their goal and then maintain their results on a lower dose than the one that got them there. So the underlying principle, that the right dose is the lowest one that actually achieves your goal, is completely sound. In fact, it's not some exotic insight, it's just how thoughtful prescribers already think about these and most other medications. Use enough to get the result, no more than you need. That part of "microdosing" is simply good prescribing wearing a trendy name.
Here's where the trend gets shaky and where the marketing does real harm. The pitch sometimes mutates into something quite different from sensible individualized dosing. It gets sold as a way to get all the benefits with none of the downsides, which isn't how medications work, or, worse, as a casual wellness add-on for people who don't actually meet the criteria for the medication at all, "just a little, for a boost." The evidence for many of these specific low-dose marketing claims is thin, and there's a basic logic problem hiding in the pitch: "barely any medication, so barely any risk" also tends to mean "barely any benefit." You can't usually have meaningful effect with zero exposure; that's not a loophole, it's just dosing. And critically, using a real prescription medication should still be a real medical decision with real screening and real monitoring, whatever the dose. A small dose of a serious medication is still a serious medication, not a supplement.
So where do I actually land on this? Individualized dosing, including genuinely lower doses when they're appropriate for a given person, is just good medicine, and we do exactly that, gladly, all the time. If a lower dose gets you where you're going with fewer side effects, wonderful, that's the goal. But "microdosing" as a marketed trend, especially when it's used as a clever way to hand a prescription medication to people who don't medically need it in the first place, deserves a hefty dose of skepticism. The name is doing a lot of work to make something casual out of something that shouldn't be.
Let me leave you with a practical tell, because I think it's the most useful thing in this whole post. If someone offers you a GLP-1 with no real screening, no questions about your history, no monitoring plan, justified with a breezy "oh, it's just a microdose, totally low-risk," that's not reassurance. That's a red flag. The casualness is the problem, not the proof of safety. A low dose given carelessly, by someone who skipped the evaluation because the dose is small, is still careless prescribing. The dose can absolutely be small. The medical seriousness around it shouldn't be. When the smallness of the dose is used as an excuse to skip the medicine part of the decision, ask more questions, not fewer.